PureIV’s compounding capability will be complete by the end of this year when its cytotoxic suite is commissioned, allowing the Shenton Park facility to provide the full range of compounded sterile medicines hospitals require.

The PureIV pharmacist-led team and has extensive experience providing clinical and compounding services in the oncology space.